Patents by Inventor Gayle Stephenson-Phillips

Gayle Stephenson-Phillips has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • POLYMER FACTOR IX MOIETY CONJUGATES
    Publication number: 20210023186
    Abstract: Conjugates of a Factor IX moiety and one or more water-soluble polymers are provided. Typically, the water-soluble polymer is poly(ethylene glycol) or a derivative thereof. Also provided (among other things) are compositions comprising the conjugates, methods of making the conjugates, and methods of administering to a patient compositions comprising the conjugates.
    Type: Application
    Filed: October 5, 2020
    Publication date: January 28, 2021
    Inventors: Mary J. Bossard, Gayle Stephenson-Phillips
  • Conjugates of an anti-TNF-alpha antibody
    Patent number: 10232042
    Abstract: Conjugates of an anti-TNF antibody and one or more nonpeptidic water-soluble polymers are provided. Typically, the nonpeptidic water-soluble polymer is poly(ethylene glycol) or a derivative thereof. Also provided, among other things, are compositions comprising conjugates, methods of making conjugates, and methods of administering compositions to a patient.
    Type: Grant
    Filed: March 27, 2017
    Date of Patent: March 19, 2019
    Assignee: Nektar Therapeutics
    Inventors: Mary J. Bossard, Gayle Stephenson-Phillips
  • CONJUGATES OF AN ANTI-TNF-ALPHA ANTIBODY
    Publication number: 20170196975
    Abstract: Conjugates of an anti-TNF antibody and one or more nonpeptidic water-soluble polymers are provided. Typically, the nonpeptidic water-soluble polymer is poly(ethylene glycol) or a derivative thereof. Also provided, among other things, are compositions comprising conjugates, methods of making conjugates, and methods of administering compositions to a patient.
    Type: Application
    Filed: March 27, 2017
    Publication date: July 13, 2017
    Inventors: Mary J. Bossard, Gayle Stephenson-Phillips
  • Conjugates of an anti-TNF-alpha antibody
    Patent number: 9636412
    Abstract: Conjugates of an anti-TNF antibody and one or more nonpeptidic water soluble polymers are provided. Typically, the nonpeptidic water soluble polymer is poly(ethylene glycol) or a derivative thereof. Also provided, among other things, are compositions comprising conjugates, methods of making conjugates, and methods of administering compositions to a patient.
    Type: Grant
    Filed: August 5, 2015
    Date of Patent: May 2, 2017
    Assignee: Nektar Therapeutics
    Inventors: Mary J. Bossard, Gayle Stephenson-Phillips
  • POLYMER FACTOR IX MOIETY CONJUGATES
    Publication number: 20170035896
    Abstract: Conjugates of a Factor IX moiety and one or more water-soluble polymers are provided. Typically, the water-soluble polymer is poly(ethylene glycol) or a derivative thereof. Also provided (among other things) are compositions comprising the conjugates, methods of making the conjugates, and methods of administering to a patient compositions comprising the conjugates.
    Type: Application
    Filed: May 17, 2016
    Publication date: February 9, 2017
    Inventors: Mary J. Bossard, Gayle Stephenson Phillips
  • Polymer factor IX moiety conjugates
    Patent number: 9347054
    Abstract: Conjugates of a Factor IX moiety and one or more water-soluble polymers are provided. Typically, the water-soluble polymer is polyethylene glycol) or a derivative thereof. Also provided (among other things) are compositions comprising the conjugates, methods of making the conjugates, and methods of administering to a patient compositions comprising the conjugates.
    Type: Grant
    Filed: November 8, 2013
    Date of Patent: May 24, 2016
    Assignee: Nektar Therapeutics
    Inventors: Mary J. Bossard, Gayle Stephenson Phillips
  • CONJUGATES OF AN ANTI-TNF-ALPHA ANTIBODY
    Publication number: 20160030587
    Abstract: Conjugates of an anti-TNF antibody and one or more nonpeptidic water soluble polymers are provided. Typically, the nonpeptidic water soluble polymer is poly(ethylene glycol) or a derivative thereof. Also provided, among other things, are compositions comprising conjugates, methods of making conjugates, and methods of administering compositions to a patient.
    Type: Application
    Filed: August 5, 2015
    Publication date: February 4, 2016
    Inventors: Mary J. Bossard, Gayle Stephenson-Phillips